| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adc Therapeutics SA (ADCT) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. ADCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 9.79M | $35.53M | - | |
| 10% | 3.85M | $13.96M | - | |
| CEO | 1.32M | $4.79M | - | |
| CFO | 488.7K | $1.77M | - | |
| Other | 421.8K | $1.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | Mallik Ameet | Chief Executive Officer | Sell | 29,731 | $4.48 | $133,194.88 | -2.5% | -40.6% | -73.7% |